Pamela Njuguna

Uptake of WHO Recommendations for First-Line Antiretroviral Therapy in Kenya, Uganda, and Zambia

E. Gakidou, Roy Burstein, H. Duber, 2015, PloS one.

Trends and Determinants of Antiretroviral Therapy Patient Monitoring Practices in Kenya and Uganda

E. Gakidou, H. Duber, E. Okiro, 2015, PloS one.

The clock is ticking: the rate and timeliness of antiretroviral therapy initiation from the time of treatment eligibility in Kenya

E. Gakidou, H. Duber, E. Dansereau, 2015, Journal of the International AIDS Society.

Prevalence of rotavirus infection among children with acute diarrhoea after rotavirus vaccine introduction in Kenya, a hospital cross-sectional study

T. Egondi, Rashmi Kumar, B. Osano, 2018, BMC Pediatrics.

The effect of facility-based antiretroviral therapy programs on outpatient services in Kenya and Uganda

Aubrey J. Levine, N. Fullman, E. Gakidou, 2017, BMC Health Services Research.

The potential to expand antiretroviral therapy by improving health facility efficiency: evidence from Kenya, Uganda, and Zambia

Aubrey J. Levine, C. Murray, A. Flaxman, 2016, BMC Medicine.

Pharmaceutical Availability across Levels of Care: Evidence from Facility Surveys in Ghana, Kenya, and Uganda

E. Gakidou, Caroline Kisia, Brendan DeCenso, 2014, PloS one.

Reasons for Ineligibility in Phase 1 and 2A HIV Vaccine Clinical Trials at Kenya Aids Vaccine Initiative (KAVI), Kenya

S. Wakasiaka, W. Jaoko, O. Anzala, 2011, PloS one.